Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G-Reference-Cited by-同舟云学术

Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G

Published:2021-10-16 Issue:21 Volume:10 Page:7673-7682
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Arai Hiroyuki¹²^ORCID,Inoue Eisuke³,Yamaguchi Kensei⁴,Boku Narikazu⁵,Hara Hiroki⁶,Nishina Tomohiro⁷,Tsuda Masahiro⁸,Shitara Kohei⁹,Shinozaki Katsunori¹⁰,Nakamura Shinichiro¹¹,Hyodo Ichinosuke¹²,Muro Kei¹³^ORCID,Sasako Mitsuru¹⁴,Terashima Masanori¹⁵,Nakajima Takako E.¹¹⁶

Affiliation:

1. Department of Clinical Oncology St. Marianna University School of Medicine Kawasaki Japan

2. Norris Comprehensive Cancer Center University of Southern California Los Angeles USA

3. Showa University Research Administration Center Showa University Tokyo Japan

4. Department of Gastroenterology The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

5. Department of Gastrointestinal Medical Oncology National Cancer Center Hospital Tokyo Japan

6. Department of Gastroenterology Saitama Cancer Center Saitama Japan

7. Department of Gastrointestinal Medical Oncology National Hospital Organization Shikoku Cancer Center Matsuyama Japan

8. Department of Gastroenterological Oncology Hyogo Cancer Center Akashi Japan

9. Gastroenterology and Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan

10. Division of Clinical Oncology Hiroshima Prefectural Hospital Hiroshima Japan

11. West Japan Oncology Group (WJOG) Data Center Division Yokohama Japan

12. Department of Gastroenterology University of Tsukuba Tsukuba Japan

13. Department of Clinical Oncology Aichi Cancer Center Nagoya Japan

14. Department of Surgery Yodogawa Christian Hospital Osaka Japan

15. Division of Gastric Surgery Shizuoka Cancer Center Nagaizumi Japan

16. Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki‐CONNECT) Kyoto University Hospital Kyoto Japan

Funder

Japan Agency for Medical Research and Development

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4303

Reference18 articles.

1. Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials

2. Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy

3. Metastatic spread in patients with gastric cancer

4. Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient Data

5. A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer;Frontiers in Oncology;2023-05-18